🔗 Share this article

Chancellor Rachel Reeves has revealed she is planning "specific measures to deal with household expense challenges" in the forthcoming financial statement.

In comments to media outlets, she stated that curbing price rises is a collective responsibility of both the government and the Bank of England.

The United Kingdom's price growth is forecast to be the most elevated among the G7 advanced economies this calendar year and next.

Potential Utility Cost Measures

It is understood the government could take action to bring down utility costs, for example by cutting the current 5% rate of value-added tax applied on energy.

Another possibility is to cut some of the regulatory levies currently included in household expenses.

Fiscal Limitations and Expert Predictions

The administration will obtain the latest assessment from the independent fiscal watchdog, the Office for Budget Responsibility, on the start of the week, which will clarify how much space there is for such measures.

The expectation from the majority of economists is that the Chancellor will have to announce tax increases or spending cuts in order to fulfill her voluntary borrowing rules.

Previously on Thursday, analysis suggested there was a twenty-two billion pound shortfall for the chancellor to fill, which is at the more modest range of expectations.

"There's a collective task between the central bank and the administration to continue tackling some of the drivers of price increases," Reeves stated to the BBC in the US capital, at the conferences of the International Monetary Fund and World Bank.

Revenue Commitments and Global Issues

While a great deal of the attention has been on likely tax rises, the chancellor said the latest figures from the OBR had not altered her pledge to campaign commitments not to increase rates on earnings tax, VAT or social security contributions.

She blamed an "uncertain global environment" with increasing international and trade tensions for the Budget tax moves, likely to be focused on those "wealthiest."

Global Trade Tensions

Referring to worries about the UK's trade ties with China she said: "Our security interests invariably are paramount."

Recent statement by China to increase export controls on critical minerals and other materials that are key for advanced tech production led US President the US President to propose an further 100% tariff on goods from the Asian country, increasing the prospect of an full-scale commercial conflict between the two economic giants.

The American finance chief labeled China's decision "commercial pressure" and "a international production power grab."

Inquired about considering the American proposal to participate in its conflict with China, the Chancellor said she was "extremely troubled" by China's actions and called on the Chinese government "to avoid restrictions and restrict access."

She said the move was "harmful for the world economy and causes further challenges."

"In my view there are fields where we need to address China, but there are also significant chances to trade with Chinese markets, including financial services and other sectors of the economic system. We've got to achieve that balance right."

The Treasury chief also confirmed she was working with international partners "regarding our own critical minerals strategy, so that we are reduced dependence."

NHS Drug Costs and Investment

Reeves also admitted that the price the National Health Service pays for drugs could increase as a consequence of current talks with the Trump administration and its drugs companies, in return for reduced taxes and funding.

A number of the world's largest pharmaceutical manufacturers have said lately that they are either delaying or abandoning projects in the UK, with some attributing the modest returns they are obtaining.

Last month, the government science advisor said the price the health service pays for drugs would must rise to halt companies and drug research funding leaving the UK.

Reeves told the BBC: "We have seen as a result of the payment system, that drug testing, recent pharmaceuticals have not been offered in the UK in the extent that they are in other EU nations."

"The objective is to ensure that individuals getting care from the NHS are can receive the finest essential drugs in the world. And so we are reviewing this situation, and... looking to attract additional investment into the UK."